Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4086.0
(-0.61%)
JPY 4086.0
(-0.61%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -51.82 Billion JPY | 56.77% |
| 2022 | -119.85 Billion JPY | 5.5% |
| 2021 | -126.83 Billion JPY | -12.59% |
| 2020 | -112.65 Billion JPY | -7.01% |
| 2019 | -105.27 Billion JPY | 2.88% |
| 2018 | -108.39 Billion JPY | 5.85% |
| 2017 | -115.13 Billion JPY | -47.44% |
| 2016 | -78.08 Billion JPY | 1.38% |
| 2015 | -79.17 Billion JPY | -15.21% |
| 2014 | -68.72 Billion JPY | -8.21% |
| 2013 | -63.51 Billion JPY | -66.59% |
| 2012 | -38.12 Billion JPY | -75.65% |
| 2011 | -21.7 Billion JPY | 7.89% |
| 2010 | -23.56 Billion JPY | -189.88% |
| 2009 | -8.12 Billion JPY | 78.28% |
| 2008 | -37.42 Billion JPY | -9.28% |
| 2007 | -34.24 Billion JPY | -35.41% |
| 2006 | -25.29 Billion JPY | 7.04% |
| 2005 | -27.2 Billion JPY | 3.18% |
| 2004 | -28.1 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -111.15 Billion JPY | -114.5% |
| 2024 Q2 | -112.45 Billion JPY | -1.17% |
| 2023 FY | -51.82 Billion JPY | 56.77% |
| 2023 Q1 | -121.1 Billion JPY | -1.04% |
| 2023 Q2 | -125.86 Billion JPY | -3.93% |
| 2023 Q4 | -51.82 Billion JPY | 52.88% |
| 2023 Q3 | -109.97 Billion JPY | 12.62% |
| 2022 Q3 | -132.75 Billion JPY | 1.81% |
| 2022 Q4 | -119.85 Billion JPY | 9.72% |
| 2022 FY | -119.85 Billion JPY | 5.5% |
| 2022 Q1 | -127.02 Billion JPY | -0.15% |
| 2022 Q2 | -135.2 Billion JPY | -6.44% |
| 2021 Q3 | -118.55 Billion JPY | 4.63% |
| 2021 Q2 | -124.31 Billion JPY | -4.49% |
| 2021 Q1 | -118.97 Billion JPY | -5.61% |
| 2021 Q4 | -126.83 Billion JPY | -6.98% |
| 2021 FY | -126.83 Billion JPY | -12.59% |
| 2020 Q3 | -110.5 Billion JPY | 4.35% |
| 2020 FY | -112.65 Billion JPY | -7.01% |
| 2020 Q1 | -99.59 Billion JPY | 5.39% |
| 2020 Q4 | -112.65 Billion JPY | -1.95% |
| 2020 Q2 | -115.52 Billion JPY | -15.99% |
| 2019 Q3 | -102.92 Billion JPY | 4.0% |
| 2019 FY | -105.27 Billion JPY | 2.88% |
| 2019 Q1 | -113.97 Billion JPY | -5.15% |
| 2019 Q4 | -105.27 Billion JPY | -2.29% |
| 2019 Q2 | -107.21 Billion JPY | 5.93% |
| 2018 FY | -108.39 Billion JPY | 5.85% |
| 2018 Q1 | -108.09 Billion JPY | 6.11% |
| 2018 Q4 | -108.39 Billion JPY | -5.85% |
| 2018 Q3 | -102.4 Billion JPY | 10.97% |
| 2018 Q2 | -115.01 Billion JPY | -6.41% |
| 2017 Q3 | -88.44 Billion JPY | -3.56% |
| 2017 Q1 | -82.84 Billion JPY | -6.09% |
| 2017 FY | -115.13 Billion JPY | -47.44% |
| 2017 Q2 | -85.4 Billion JPY | -3.09% |
| 2017 Q4 | -115.13 Billion JPY | -30.18% |
| 2016 Q2 | -84.81 Billion JPY | -9.63% |
| 2016 Q4 | -78.08 Billion JPY | -5.1% |
| 2016 Q3 | -74.3 Billion JPY | 12.4% |
| 2016 Q1 | -77.36 Billion JPY | 2.3% |
| 2016 FY | -78.08 Billion JPY | 1.38% |
| 2015 Q4 | -79.17 Billion JPY | -10.76% |
| 2015 Q1 | -69.55 Billion JPY | -1.2% |
| 2015 Q2 | -77.58 Billion JPY | -11.56% |
| 2015 FY | -79.17 Billion JPY | -15.21% |
| 2015 Q3 | -71.48 Billion JPY | 7.87% |
| 2014 FY | -68.72 Billion JPY | -8.21% |
| 2014 Q1 | -61.03 Billion JPY | 3.9% |
| 2014 Q4 | -68.72 Billion JPY | -6.56% |
| 2014 Q3 | -64.49 Billion JPY | 5.91% |
| 2014 Q2 | -68.54 Billion JPY | -12.3% |
| 2013 Q3 | -51.44 Billion JPY | -1.2% |
| 2013 Q4 | -63.51 Billion JPY | -23.45% |
| 2013 FY | -63.51 Billion JPY | -66.59% |
| 2013 Q1 | -42.69 Billion JPY | -12.0% |
| 2013 Q2 | -50.83 Billion JPY | -19.06% |
| 2012 FY | -38.12 Billion JPY | -75.65% |
| 2012 Q1 | -26.03 Billion JPY | -19.94% |
| 2012 Q3 | -28.51 Billion JPY | 1.45% |
| 2012 Q4 | -38.12 Billion JPY | -33.72% |
| 2012 Q2 | -28.93 Billion JPY | -11.12% |
| 2011 Q1 | -11.57 Billion JPY | 50.86% |
| 2011 Q2 | -14.17 Billion JPY | -22.39% |
| 2011 Q4 | -21.7 Billion JPY | -42.13% |
| 2011 Q3 | -15.27 Billion JPY | -7.76% |
| 2011 FY | -21.7 Billion JPY | 7.89% |
| 2010 Q3 | -15.81 Billion JPY | 11.28% |
| 2010 Q2 | -17.82 Billion JPY | -53.43% |
| 2010 FY | -23.56 Billion JPY | -189.88% |
| 2010 Q1 | -11.61 Billion JPY | -42.9% |
| 2010 Q4 | -23.56 Billion JPY | -49.04% |
| 2009 Q2 | -1.6 Billion JPY | 94.52% |
| 2009 FY | -8.12 Billion JPY | 78.28% |
| 2009 Q4 | -8.12 Billion JPY | -1106.08% |
| 2009 Q3 | -674 Million JPY | 57.93% |
| 2009 Q1 | -29.22 Billion JPY | 0.0% |
| 2008 FY | -37.42 Billion JPY | -9.28% |
| 2007 FY | -34.24 Billion JPY | -35.41% |
| 2006 FY | -25.29 Billion JPY | 7.04% |
| 2005 FY | -27.2 Billion JPY | 3.18% |
| 2004 FY | -28.1 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 4330.286% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 101.182% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 113.293% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 85.043% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -1353.964% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | -22.927% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 15.703% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 47.085% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -7669.265% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -57.41% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 781.676% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 765.994% |
| Tsumura & Co. | 1.61 Billion JPY | 3308.731% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | -17.348% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | -50.481% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 130.005% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 294.64% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 278.806% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 834.008% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 7460.938% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 964.836% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -695.166% |
| MedRx Co., Ltd | -1.72 Billion JPY | -2912.849% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -494.519% |
| Solasia Pharma K.K. | -668 Million JPY | -7657.635% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -3422.992% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -614.477% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 191.683% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -1650.252% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 47.352% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -365.614% |